SCHEMBL7259309

SCHEMBL7259309

NC(=O)Nc1ccc(Cl)cc1C(=O)O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.70
HSD17B10 Q99714 2/20 0.70
SERPINE1 P05121 6/20 0.61
AKR1C4 P17516 1/20 0.57
AKR1C3 P42330 1/20 0.57
AKR1C2 P52895 1/20 0.57
AKR1C1 Q04828 1/20 0.57
ALDH1A1 P00352 3/20 0.53
TP53 P04637 1/20 0.53
GAA P10253 3/20 0.53
GLA P06280 1/20 0.53
ACLY P53396 1/20 0.53
PPARG P37231 1/20 0.52
PPARA Q07869 1/20 0.52
CA1 P00915 2/20 0.52
CA2 P00918 2/20 0.52
CA12 O43570 1/20 0.52
CA7 P43166 1/20 0.52
CA9 Q16790 1/20 0.52
LMNA P02545 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7255416 0.86 GRIK1 (0.67) KDM4EALDH1A1
SCHEMBL1016189 0.85 KDM4E (0.74) KDM4EHSD17B10SERPINE1AKR1C4AKR1C3
SCHEMBL27611956 0.83 MAPT (0.72) KDM4ESERPINE1ALDH1A1TP53GAA
SCHEMBL9681911 0.83 KDM4E (0.66) KDM4EHSD17B10SERPINE1AKR1C4AKR1C3
SCHEMBL7988908 0.82 KDM4E (0.70) KDM4EHSD17B10SERPINE1AKR1C4AKR1C3
SCHEMBL7045036 0.82 KDM4E (1.00) KDM4EHSD17B10SERPINE1AKR1C4AKR1C3
Hydrochloric Acid SCHEMBL6623261 0.81 KDM4E (0.64) KDM4EHSD17B10SERPINE1AKR1C4AKR1C3
SCHEMBL28253565 0.81 KMT2A (0.57) KDM4EHSD17B10ALDH1A1CA1CA2
SCHEMBL6351321 0.81 SERPINE1 (0.89) KDM4EHSD17B10SERPINE1AKR1C4AKR1C3
SCHEMBL11604753 0.81 KDM4E (0.68) KDM4EHSD17B10SERPINE1AKR1C4AKR1C3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2003055866-A1 QUINAZOLINE AND QUINOLINE DERIVATIVE COMPOUNDS AS INHIBITORS OF PROLYLPEPTIDASE, INDUCERS OF APOPTOSIS AND CANCER TREATMENT AGENTS BAYER PHARMACEUTICALS CORPORATION (US) 2003-07-10 WO disclosed